Latest Sarcoma Stories
SAN DIEGO, Dec.
CALGARY, Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
CALGARY, Nov. 14 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr.
SALT LAKE CITY, Nov.
Infinity Pharmaceuticals, a cancer drug discovery and development company, has initiated a Phase III registration trial of IPI-504, its lead inhibitor of heat shock protein 90, in patients with refractory gastrointestinal stromal tumors.
Ziopharm Oncology, a biopharmaceutical company, has announced that the European Medicines Agency's Committee for Orphan Medicinal Products has issued a positive opinion regarding the company's application for orphan medicinal product designation for palifosfamide in the treatment of soft tissue sarcoma.
SALT LAKE CITY, Sept. 23, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp.
REDWOOD CITY, Calif., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLDD), today announced that it has initiated a Phase 1/2 clinical trial of TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
SALT LAKE CITY, Sept.
ZIOPHARM Oncology, Inc.
Kaposi's sarcoma-associated herpesvirus (KSHV) one of seven currently known human cancer virus, is also the eighth human herpesvirus. Kaposi's sarcoma, caused by the virus, is common in AIDS patients, primary effusion lymphoma, and some types of multicentric Castelman's disease. Moritz Kaposi discovered the blood vessel tumor, in 1872, which would eventually be names Kaposi's sarcoma. It was originally though that KS was of Jewish and Mediterranean origins until it was found to be common...
- a meat pie that is usually eaten at Christmas in Quebec